Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19855717 | 1.00 | TSHR (0.37) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL19856001 | 0.99 | TSHR (0.36) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL19855581 | 0.99 | TSHR (0.39) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL20882173 | 0.99 | TSHR (0.36) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL19855606 | 0.97 | TSHR (0.40) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL20882663 | 0.96 | TSHR (0.39) | TSHRTP53PKMMEN1HTT | |
| SCHEMBL19855673 | 0.96 | TP53 (0.34) | TP53PKMMEN1HTTKMT2A | |
| SCHEMBL19855398 | 0.96 | TP53 (0.34) | TP53PKMMEN1HTTKMT2A | |
| SCHEMBL19854137 | 0.96 | TP53 (0.34) | TP53PKMMEN1HTTKMT2A | |
| SCHEMBL19854089 | 0.94 | TP53 (0.33) | TP53PKMMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220128867-A1 | SUBSTRATE AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2022-04-28 | — | — | US | disclosed |
| US-20210223635-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-07-22 | — | — | US | disclosed |
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-20210171831-A1 | ALIGNMENT AID, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2021-06-10 | — | — | US | disclosed |
| US-10982146-B2 | Liquid crystal composition, liquid crystal element, and use of liquid crystal composition in liquid crystal element | JNC CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| WO-2020116380-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2020-06-11 | — | — | WO | disclosed |
| US-20200183203-A1 | REVERSE MODE LIQUID CRYSTAL DEVICE | JNC CORPORATION (JP) | 2020-06-11 | — | — | US | disclosed |
| US-10428275-B2 | Method for manufacturing liquid crystal display device and liquid crystal display device | JNC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-20190225887-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| US-20190225886-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL ELEMENT, AND USE OF LIQUID CRYSTAL COMPOSITION IN LIQUID CRYSTAL ELEMENT | JNC CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-3466918-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292463-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | SP1, PYM1, MPEG1 | TSHR 3095/4885TP53 1267/4885PKM 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.